, Tracking Stock Market Picks
Enter Symbol:
Iomai Corporation (IOMI) [hlAlert]

up 224.75 %

Iomai Corporation (IOMI) rated Buy

Posted on: Wednesday,  Aug 1, 2007  9:25 AM ET by UBS

UBS rated Buy Iomai Corporation (IOMI) on 08/01/2007, when the stock price was $2.02. Since then,
Iomai Corporation has gained 224.75% as of 09/25/2008's recent price of $6.56.
If you would have followed this UBS's recommendation on IOMI, you would have gained 224.75% of your investment in 421 days.

Iomai Corporation is pioneering the delivery to the skin of potent biological molecules for vaccination and immuno-modulation that will prevent or treat a broad range of diseases. Transcutaneous immunization, developed at Walter Reed Army Institute of Research, is licensed exclusively to Iomai Corporation. Transcutaneous immunization is its proprietary platform for the development of the next generation of vaccines that will replace the needle and syringe and, it believes that it will result in more effective prevention and treatment of disease.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/1/2007 9:25 AM Buy
as of 5/23/2009
1 Week   
1 Month   
3 Months   
1 YTD up  539.80 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy